{"id":12031,"date":"2021-09-03T07:14:39","date_gmt":"2021-09-02T21:14:39","guid":{"rendered":"https:\/\/unshackledminds.com\/?p=12031"},"modified":"2021-09-05T11:36:19","modified_gmt":"2021-09-05T01:36:19","slug":"pfizer-is-now-developing-a-twice-per-day-covid-pill-that-must-be-taken-alongside-vaccines","status":"publish","type":"post","link":"https:\/\/unshackledminds.com\/pfizer-is-now-developing-a-twice-per-day-covid-pill-that-must-be-taken-alongside-vaccines\/","title":{"rendered":"Pfizer Is Now Developing A Twice-Per-Day COVID Pill That Must Be Taken Alongside Vaccines"},"content":{"rendered":"\n

Pfizer is so confident the pill will be approved and likely mandated that it has started production before the end of clinical trials<\/h2>\n\n\n\n

Gabriel Keane | National File<\/a> September 1st 2021<\/p>\n\n\n\n

\"\"
Image Credit:Yulia Reznikov \/ Getty<\/figcaption><\/figure>\n\n\n\n

Pharmaceutical megacorporation pfizer is now developing a COVID pill that is meant to be taken alongside the COVID vaccines that have already made the company a staggering amount of money. The new pill is expected to be released by the end of the year and will be required to be taken twice per day.<\/h4>\n\n\n\n

\u201cSuccess against #COVID19 will likely require both vaccines & treatments,\u201d Pfizer CEO Albert Bourla said on Wednesday. \u201cWe\u2019re pleased to share we\u2019ve started a Phase 2\/3 study of our oral antiviral candidate-specifically designed to combat SARS-CoV-2-in non-hospitalized, low-risk adults.\u201d<\/p>\n\n\n\n

\n

Success against #COVID19<\/a> will likely require both vaccines & treatments. We\u2019re pleased to share we\u2019ve started a Phase 2\/3 study of our oral antiviral candidate\u2014specifically designed to combat SARS-CoV-2\u2014in non-hospitalized, low-risk adults: https:\/\/t.co\/su5VtfbWPX<\/a><\/p>— Albert Bourla (@AlbertBourla) September 1, 2021<\/a><\/blockquote>